N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
BackgroundAlthough the RNA modification N6-methyladenosine ZC3H13 has been found to play vital regulatory roles in many types of cancers, its role in predicting the tumor immune microenvironment (TME) and response to immune checkpoint blockade (ICB) in kidney renal clear cell carcinoma (KIRC) remain...
Main Authors: | Tao Guo, Hongxiang Duan, Jinbo Chen, Jinhui Liu, Belaydi Othmane, Jiao Hu, Huihuang Li, Xiongbing Zu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.718644/full |
Similar Items
-
RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
by: Huihuang Li, et al.
Published: (2021-03-01) -
N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
by: Chao Quan, et al.
Published: (2021-08-01) -
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
by: Peng-Ju Gong, et al.
Published: (2020-12-01) -
m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-07-01) -
Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation
by: Wenqing Lu, et al.
Published: (2021-02-01)